226880-80-4

Upstream product

• 620-02-0 5-Methylfurfural 
• 100945-15-1 N-(benzyloxycarbonyl)phosphonoglycine trimethyl ester 

Downstream Products

• 226880-87-1 methyl (2R)-(-)-2-benzyloxycarbonylamino-3-(5-methylfuran-2-yl)propanoate 
• 904682-43-5 methyl 2-benzyloxycarbonylamino-3-(5-methylfuran-2-yl)propanoate 
• 904682-25-3 (+)-benzyl (1R)-2-(5-methyl-2-furyl)-1-({[tert-butyl(dimethyl)silyl]oxy}methyl)ethyl(prop-2-ynyl)carbamate 
• 904682-21-9 (+)-benzyl (1R)-2-(5-methyl-2-furyl)-1-({[tert-butyl(dimethyl)silyl]oxy}methyl)ethylcarbamate 
• 904682-18-4 (-)-benzyl (1R)-[2-(5-methyl-2-furyl)-1-(hydroxymethyl)ethyl]carbamate 
• 904682-49-1 4-bromo-N-{2-{[tert-butyl(dimethyl)silyl]oxy}-1-[(5-methyl-2-furyl)methyl]ethyl}-N-prop-2-ynylbenzenesulfonamide 
• 904682-16-2 (+)-4-bromo-N-{(1R)-2-{[tert-butyl(dimethyl)silyl]oxy}-1-[(5-methyl-2-furyl)methyl]ethyl}-N-prop-2-ynylbenzenesulfonamide 
• 904682-48-0 4-bromo-N-{2-hydroxy-1-[(5-methyl-2-furyl)methyl]ethyl}-N-prop-2-ynylbenzenesulfonamide 
• 904682-14-0 (+)-4-bromo-N-{(1R)-2-hydroxy-1-[(5-methyl-2-furyl)methyl]ethyl}-N-prop-2-ynylbenzenesulfonamide 
• 904682-47-9 4-bromo-N-[1-hydroxymethyl-2-(5-methyl-2-furyl)ethyl]benzenesulfonamide 
• 904682-13-9 (+)-4-bromo-N-[(1R)-1-hydroxymethyl-2-(5-methyl-2-furyl)ethyl]benzenesulfonamide 
• 904682-45-7 methyl [(4-bromobenzenesulfonyl)-prop-2-ynyl-amino]-3-(5-methylfuran-2-yl)propanoate 
• 904682-11-7 methyl (+)-(2R)-[(4-bromobenzenesulfonyl)-prop-2-ynyl-amino]-3-(5-methylfuran-2-yl)propanoate 
• 904682-44-6 methyl 2-{[(4-bromophenyl)sulfonyl]amino}-3-(5-methyl-2-furyl)propanoate 

Relevant academic research and scientific papers

Asymmetric rhodium-catalyzed hydrogenation meets gold-catalyzed cyclization: Enantioselective synthesis of 8-hydroxytetrahydroisoquinolines

Different furyl-substituted (Z)-dehydroamino acid derivatives were hydrogenated with the rhodium/Mandyphos(OMe)-system to give enantiomeric excesses between 80 and 98%. The absolute configuration of the newly formed stereogenic center was determined by an